51成人动漫

Dermatology >

Skin Cancer

News, opinions and meeting coverage in dermatology.

ASCO: Targeting PD-1 Works in Advanced Melanoma

CHICAGO -- Two studies indicate that using investigative immunotherapy drugs improves survival and response in patients with metastatic melanoma, researchers said here.

ASCO: Ipilimumab Cuts Relapse but Safety Issues Remain

CHICAGO -- High-risk melanoma patients have a reduced level of relapse if they are taking the monoclonal antibody ipilimumab (Yervoy) when compared with placebo, researchers said here.

OncoBriefs: Myeloma Tx, In Situ Melanoma

Superficial melanoma conferred a risk of recurrent invasive melanoma similar to that of primary invasive melanoma, Australian investigators reported. The study is one of several oncology-related news items summarized in OncoBriefs.

Prime Time: Skin Docs Name 5 Unnecessary Procedures

The American Academy of Dermatology joined more than 80 other medical societies in the Choosing Wisely campaign, naming five treatments or procedures that may not be necessary. Prime Time is a blog by Chris Kaiser for those interested in primary care.

Losing a Tattoo, Gaining a Tumor

An unintended consequence of laser tattoo removal in a 29-year-old man was a diagnosis of malignant melanoma, according to a German case report.

Medicare to Pay for More FDG-PET Scans

WASHINGTON -- Up to three scans using 18F-fluorodeoxyglucose-enhanced positron emission tomography technology can be covered by Medicare for oncology treatment planning, the Centers for Medicare and Medicaid Services said.

ASCO: Herpes-Derived Tx for Melanoma?

CHICAGO -- Intralesional injection of an oncolytic therapy significantly increased the durable response rate in advanced melanoma compared with a control therapy, according to results of a randomized trial.

ASCO: Immune Therapy Durable in Melanoma

CHICAGO -- A therapy aimed at reviving the immune response to advanced melanoma generated durable responses in long-term follow-up of an early clinical trial, a researcher said here.

Melanoma Tx Ups Survival, but Very Pricey

LAS VEGAS -- The oral BRAF inhibitor vemurafenib (Zelboraf) increased survival in patients with metastatic melanoma, but the cost may not justify its use in a state Medicaid program, an analysis suggested.

Smokers Have Higher Squamous Cell Skin Ca Risk

Smokers have a more than 50% increase in risk for squamous cell carcinoma of the skin, and the risk remained elevated, even among those who'd kicked the habit, researchers found.

Doctors Say 45 Common Tests 'Overused'

Nine specialty groups have listed tests and treatments that are frequently overused, such as antibiotics for sinus attacks and CT scans for low back pain, in the first phase of a long-term project.

SID: No Skin Cancer Risk Seen With Prednisone

PHOENIX -- Use of systemic corticosteroids did not increase the risk of nonmelanoma skin cancer in a prospective study, contradicting previous evidence from several retrospective studies, investigators reported here.

'Ugly Duckling' Moles May Be Melanomas

NEW YORK -- An irregularly pigmented mole that looks different from other irregularly pigmented moles in the same person -- an "ugly duckling" -- is likely to be a malignant melanoma, according to a preliminary study.

Fast-Growing Melanomas Give Clues to Severity

MELBOURNE, Australia -- Rapidly growing primary cutaneous melanomas have characteristic features that signal the need for immediate and aggressive medical intervention, said researchers here.

Chemical Peel Wins by Nose for Facial Skin Lesions

STANFORD, Calif. -- For patients with too many facial actinic keratoses to freeze them all off with liquid nitrogen, a face-to-face comparison of three alternative approaches gave the edge to a chemical peel by a nose.